Scientists at KAIST have developed a groundbreaking method to convert colon cancer cells into healthy ones using a ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

Amivantamab is under clinical development by Johnson & Johnson and currently in Phase III for Metastatic Colorectal Cancer.

Floats covered in flowers hit the streets for the annual Rose Parade. A cancer survivor from the Chicago area was on the City ...

Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling ...

3. In July, the FDA approved a new screening test for CRC that only requires a sample of blood. The test, created by Palo Alto, Calif.-based Guardant Health, was able to detect 83% of colorectal ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Peritoneal Cancer.

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Korean scientists at KAIST have developed ground-breaking technology that transforms colon cancer cells into normal cells, ...

A common deworming drug used in dogs and cats called fenbendazole may help to cure cancer in humans, but doctors urge caution ...

The age of testing for colorectal cancer has been pushed from 50 to 45, and it is even earlier for at-risk patients because of the rise in the number of young adults being diagnosed with the disease.